Companies: 10,795·Total market cap: $144.5T
Nu Skin Enterprises, Inc.

Nu Skin Enterprises, Inc.

NUSNYSEConsumer Defensive● Active
$5.25
$-0.12(-2.23%)
Market Cap$254890351
P/E Ratio
52W High$14.62
52W Low$5.25
Overview

Nu Skin Enterprises, Inc. (NUS) Stock Forecast & Analyst Price Target

Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.

nus · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026

Analyst Rating & Consensus

Based on 11 Wall Street analysts in the past 3 months

SellBuy

Hold

11 analysts

consensus

Rating Breakdown

Strong Buy
0
Buy
0
Hold
10
Sell
1
Strong Sell
0
Total: 11 · Buy rate: 0.0%

12-Month Price Target

High

$11.00

Consensus

$11.00

+105.8% upside

Low

$11.00

Median: $11 · Last Close: $5.34

The Nu Skin Enterprises, Inc. (NUS) analyst consensus is Hold, based on ratings from 11 Wall Street analysts over the past 3 months. The average 12-month NUS price target is $11.00, representing +105.8% upside from the current price of $5.34.

12-Month Price Target Forecast

Historical closing prices + analyst 12-month price target forecast cone

Analyst price target coverage is insufficient to generate a forecast chart for this stock.

Short-Term Price Prediction

Low Activity

Algorithmically generated · Updated daily

DatePredicted PriceChange
2026-06-09$5.094.73%

1-day model range: $5.03–$5.16. Peak: $5.16 (-4.73%).

Long-Term Stock Price Prediction

Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031

YearAvg PriceChange
2027-50.0%
2028-62.5%
2029-67.2%
2030-69.2%
2031-70.2%
Confidence:Very Low
⚠️ 2027 projections carry Very Low confidence. Treat as directional guidance only.

Stock Forecast Based on Technical Analysis

14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency

🚫

Insufficient Trading Activity — Sentiment Signals Disabled

This stock has very low trading volume (ZOMBIE condition). Sentiment analysis requires sufficient price action. RSI and MACD values below are still shown for reference.

RSI (14)31.8
MACDBEARISH

Moving Averages · NUS · Jun 8, 2026

Simple Moving Average (SMA)
MA 5$5.38SELL
MA 10$5.62SELL
MA 20$5.87SELL
MA 50$6.80SELL
MA 100$7.89SELL
MA 200$9.34SELL
Current $NUS · Price above MA = BUY signal
Exponential Moving Average (EMA)
EMA 5$5.42SELL
EMA 10$5.58SELL
EMA 20$5.91SELL
EMA 50$6.66SELL
EMA 100$7.53SELL
EMA 200$8.34SELL
Current $NUS · Price above MA = BUY signal
How we calculate: Technical sentiment is derived from 14 indicators — SMA(5,10,20,50,100,200), EMA(5,10,20,50,100,200), RSI(14), and MACD(12,26,9) — calculated from historical EOD price data. BUY = current price above MA; SELL = below. 14 TA signals + historical EOD price data · Updated daily. Independent of analyst consensus data. Not investment advice.

Latest Analyst Ratings & Upgrades

Filter:
DA Davidson2024-12-20
Maintains
NeutralNeutral
Citigroup2024-10-22
Maintains
NeutralNeutral
DA Davidson2024-08-12
Maintains
NeutralNeutral
Citigroup2024-08-09
Maintains
NeutralNeutral
DA Davidson2024-05-09
Maintains
NeutralNeutral
DA Davidson2024-01-05
Maintains
NeutralNeutral
Stifel2023-10-16
Maintains
HoldHold
Citigroup2023-09-29
Maintains
NeutralNeutral
DA Davidson2023-08-03
Maintains
NeutralNeutral
Stifel2023-08-02
Maintains
HoldHold

Wall Street analysts have recently issued updated ratings on Nu Skin Enterprises, Inc. (NUS) stock. Of the recent 113 rating actions, 10 were upgrades and 20 were downgrades. 11 analysts currently cover NUS.

Analyst Recommendation Trends

Buy ratings00
Hold ratings11
Sell ratings00

NUS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.

Financial Forecast: EPS & Revenue Estimates

Revenue This Year

$1.8B

↑ 23.1% YoY

Revenue Next Year

$1.7B

↓ 6.6% YoY

EPS This Year

$-2.99

EPS Next Year

$0.68

↓ 122.6% YoY

EPS ForecastReported vs Estimated

Reported EPSHistorical estimateAnalyst forecast (future)

Analysts forecast NUS EPS of $-2.99 for the current fiscal year, based on estimates from 1 analysts. The NUS revenue forecast is $1.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.

About Forecast & Price Prediction

The NUS stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus NUS price target is $11.00 (+105.8% upside), with an analyst consensus of Hold.

The NUS short-term stock prediction for tomorrow is $5.09 (-4.73%). The NUS stock prediction for 2030 projects a range of $2–$2.

Nu Skin Enterprises, Inc. trades on NYSE under the ticker NUS. The NUS stock outlook for 2027 is broadly mixed, supported by a Hold consensus among 0% of covering analysts.

FAQ answers synthesize analyst targets, estimates, and on-page model outputs where shown.

Frequently asked questions

NUS forecast · 8 questions

According to 11 Wall Street analysts, the average 12-month NUS price target is $11.00, with a high forecast of $11.00 and a low of $11.00. The median price target is shown in the chart above when available. This implies +105.8% potential upside from the current price of $5.34.

NUS price targetWhat is NUS price targetNUS analyst price targetNUS 12-month target

· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)

⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.